OBJECTIVE: The goals of this study were to elucidate reasons why patients did or did not receive intracranial pressure (ICP) monitoring and to describe factors influencing hospital mortality after severe traumatic brain injury (TBI). DESIGN: Prospective multicenter cohort study. PATIENTS AND PARTICIPANTS: 88,274 patients consecutively admitted to 32 medical, surgical and mixed Austrian ICUs between 1998 and 2004. INTERVENTIONS: None. MEASUREMENTS AND RESULTS: 1,856 patients (2.1% of all ICU admissions) exhibited severe TBI (GCS < 9); of these, 1,031 (56%) had ICP monitoring. The "worst" and the "best" cases were both less likely to receive ICP monitoring. Younger patients, female patients, and patients with isolated TBI were more likely to receive ICP monitoring. Compared with large centers ICP was monitored more frequently [odds ratio (OR) 3.09, CI 2.42-3.94] in medium-sized centers. The 20% of patients with the highest likelihood to receive ICP monitoring were monitored in 91% of cases, and had the lowest hospital mortality (31%, OR 0.78, CI 0.37-1.64). Multivariate analysis revealed that severity of illness, TBI severity, isolated TBI, and the number of cases treated per year were associated with hospital outcome. Compared with the large centers, ORs for hospital mortality were 1.85 (CI 1.42-2.40) for patients from medium-sized centers and 1.91 (CI 1.24-2.93) for patients from small centers. CONCLUSIONS: ICP monitoring may possibly have some beneficial effects, but this needs further evaluation. Patients with severe TBI should be admitted to experienced centers with high patient volumes since this might improve hospital mortality rates.
OBJECTIVE: The goals of this study were to elucidate reasons why patients did or did not receive intracranial pressure (ICP) monitoring and to describe factors influencing hospital mortality after severe traumatic brain injury (TBI). DESIGN: Prospective multicenter cohort study. PATIENTS AND PARTICIPANTS: 88,274 patients consecutively admitted to 32 medical, surgical and mixed Austrian ICUs between 1998 and 2004. INTERVENTIONS: None. MEASUREMENTS AND RESULTS: 1,856 patients (2.1% of all ICU admissions) exhibited severe TBI (GCS < 9); of these, 1,031 (56%) had ICP monitoring. The "worst" and the "best" cases were both less likely to receive ICP monitoring. Younger patients, female patients, and patients with isolated TBI were more likely to receive ICP monitoring. Compared with large centers ICP was monitored more frequently [odds ratio (OR) 3.09, CI 2.42-3.94] in medium-sized centers. The 20% of patients with the highest likelihood to receive ICP monitoring were monitored in 91% of cases, and had the lowest hospital mortality (31%, OR 0.78, CI 0.37-1.64). Multivariate analysis revealed that severity of illness, TBI severity, isolated TBI, and the number of cases treated per year were associated with hospital outcome. Compared with the large centers, ORs for hospital mortality were 1.85 (CI 1.42-2.40) for patients from medium-sized centers and 1.91 (CI 1.24-2.93) for patients from small centers. CONCLUSIONS: ICP monitoring may possibly have some beneficial effects, but this needs further evaluation. Patients with severe TBI should be admitted to experienced centers with high patient volumes since this might improve hospital mortality rates.
Authors: F Procaccio; N Stocchetti; G Citerio; M Berardino; L Beretta; F Della Corte; D D'Avella; G L Brambilla; R Delfini; F Servadei; G Tomei Journal: J Neurosurg Sci Date: 2000-03 Impact factor: 2.279
Authors: N Stocchetti; K I Penny; M Dearden; R Braakman; F Cohadon; F Iannotti; F Lapierre; A Karimi; A Maas; G D Murray; J Ohman; L Persson; F Servadei; G M Teasdale; T Trojanowski; A Unterberg Journal: Intensive Care Med Date: 2001-02 Impact factor: 17.440
Authors: P G Metnitz; H Vesely; A Valentin; C Popow; M Hiesmayr; K Lenz; C G Krenn; H Steltzer Journal: Crit Care Med Date: 1999-08 Impact factor: 7.598
Authors: Hilaire J Thompson; Frederick P Rivara; Gregory J Jurkovich; Jin Wang; Avery B Nathens; Ellen J MacKenzie Journal: Crit Care Med Date: 2008-01 Impact factor: 7.598
Authors: L F Marshall; A I Maas; S B Marshall; A Bricolo; M Fearnside; F Iannotti; M R Klauber; J Lagarrigue; R Lobato; L Persson; J D Pickard; J Piek; F Servadei; G N Wellis; G F Morris; E D Means; B Musch Journal: J Neurosurg Date: 1998-10 Impact factor: 5.115
Authors: Randall M Chesnut; Nancy Temkin; Sureyya Dikmen; Carlos Rondina; Walter Videtta; Gustavo Petroni; Silvia Lujan; Victor Alanis; Antonio Falcao; Gustavo de la Fuenta; Luis Gonzalez; Manuel Jibaja; Arturo Lavarden; Freddy Sandi; Roberto Mérida; Ricardo Romero; Jim Pridgeon; Jason Barber; Joan Machamer; Kelley Chaddock Journal: J Neurotrauma Date: 2017-09-26 Impact factor: 5.269
Authors: Aziz S Alali; Robert A Fowler; Todd G Mainprize; Damon C Scales; Alexander Kiss; Charles de Mestral; Joel G Ray; Avery B Nathens Journal: J Neurotrauma Date: 2013-07-11 Impact factor: 5.269
Authors: Johannes Leitgeb; Walter Mauritz; Alexandra Brazinova; Marek Majdan; Ingrid Wilbacher Journal: Arch Orthop Trauma Surg Date: 2013-03-05 Impact factor: 3.067